NCT00651222已完成不适用
Influence of Androgen Suppression Therapy for Prostate Cancer on the Timing and Onset of Fatal Myocardial Infarctions in Men Undergoing Prostate Brachytherapy
Prostate Cancer Foundation of Chicago1 个研究点 分布在 1 个国家开始时间: 2008年4月2日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 试验地点
- 1
研究概览
简要总结
The purpose of this study is to review cause of death in patients undergoing prostate brachytherapy at a single institution. Furthermore, we are analyzing patients undergoing androgen deprivation therapy and whether or not this contributed to cardiovascular deaths, specifically myocardial infarction.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •Deceased anytime after prostate brachytherapy treatment
排除标准
- •Patients whose cause of death was unable to be determined
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Effect of ADT in Chinese Male With Prostate CancerProstate CancerNCT04341324Chinese University of Hong Kong60
终止
2 期
Enzalutamide for Bladder Cancer ChemopreventionBladder CancerNCT02605863University of Rochester1
已完成
4 期
Study to Monitor the Effects of Androgen Suppression Treatment on the HeartProstate CancerNCT01230905Ottawa Heart Institute Research Corporation181
已完成
不适用
Effect of Androgen Suppression on Bone Loss in Patients With or Without Bone Metastases Secondary to Prostate CancerProstate CancerOsteoporosisNCT00003903University of Rochester150
招募中
3 期
Impact of Hormonal Therapy on Prostate Cancer Recurrence After Radical ProstatectomyProstate CancerNCT05169112Ottawa Hospital Research Institute72